UV1
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for UV1, covering 2025-01-14 to 2026-02-27. Get the full timeline:
Most recent: Clinical Trial Update: Olaparib, Durvalumab and UV1 in Relapsed Ovarian Cancer [Phase 2]